Publication details
Educational V4 Platform for capacity building in oncology
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Workshop |
| MU Faculty or unit | |
| Citation | |
| Description | For cooperation between hospitals, specialized workplaces, and clinical trial sponsors, the key is to set up appropriate processes and effective communication through trained specialists - clinical trial coordinators, without whom clinical trials, especially in oncology workplaces, would no longer be feasible. This is the main reason why PharmAround organizes this project to establish an academic network across all participating V4 countries. The main goal is to create a training center for clinical trial study coordinators, and creating a comprehensive educational platform for clinical trial research staff in oncology is the primary objective. We created a comprehensive training syllabus divided into specific work packages (WPs) to achieve this goal. To be effective, WPs will be held in two days training course. We split each WP into the education and skills parts to create a more dynamic and practice-oriented event. To reflect the current situation in Europe and keep flexibility, we divide our four packages into four online meetings. The key targets are: to alleviate the shortage of study researchers by trained study coordinators and study nurses; increase the interest in academic clinical research among physicians and other research staff; enhance efficiency and save the time of professional staff through training and workshops in created training centers; support the education and training of postgraduate students and professionals, including internships; increase knowledge or awareness of clinical trial procedures and standards in those countries, and support the training and exchange of information for the regulatory representatives and EC members within the countries, including internships. This project is supported by Visegrad Funds. The VISEGRAD PROJECT PARTNERS are: Masaryk Memorial Cancer Institution, Pavol Jozef Safarik University in Kosice, the Faculty of Medicine – SLOVACRIN, Maria Skłodowska-Curie National Institute of Oncology, DÉL-PESTI CENTRUMKÓRHÁZ |